ConductScience.org, home

Gene · 4591

NIH grants974

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleTRIM37 papersNewest fiscal year
F30CA203271Identifying causes and consequences of centrosome amplification in cancer12019
K08AI116909Noncanonical NFkB Pathway-Mediated Mechanisms of Common Variable Immunodeficiency12019
K08CA193915The Mechanism of Tumor Formation in Beckwith-Wiedemann Syndrome12019
K23CA201594Breaking immune tolerance to Survivin in Multiple Myeloma12019
P01CA091955Barrett's Esophagus: Predictors of Progression12019
R00CA204602A functional genomics approach to determine the mechanism of cellular response to new anti-cancer12019
R01AI116585TRIM9-mediated anti-viral immune pathway12019
R01AR059130Role of Polo-Like Kinase-1 in Melanocytic Transformation12019
R01CA178445The role of wild-type KRAS in the context of tumor profession and metastasis12019
R01CA188096Targeting Autophagy in Hereditary Breast Cancer12019
R01CA190176Effector T Cell Trafficking in Ovarian Cancer12019
R01CA192399Identifying tumor suppressor targets of SIRT6 in lung cancer12019
R01CA216863Chemical Inhibitors of 15-prostaglandin dehydrogenase Potentiate Hematopoietic Stem Cell Transplantation12019
R01EB022106Improved ultrasound imaging using elevated acoustic output12019
R01GM067761Functional Genomic Analysis by RNAi Screening in Drosophila Cells12019
R01GM084947Drosophila Transgenic RNAi Resource Project12019
R01NS037766Cytokines in Glial Cells and EAE Brain12019
R21CA219252HNRNPA2B1 as a reader of RNA methylation in breast cancer12019
R21GM129652Rapid screening of gene-edited cells12019
R21NS111768Targeting epigenetic modifiers of androgen receptor activity and toxicity in SBMA12019

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4591/grants?page=24